Cardiovascular Function in COPD Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

March 29, 2017

Primary Completion Date

March 5, 2018

Study Completion Date

March 26, 2018

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG

Tiotropium

Fixed Dose Combination

DRUG

Olodaterol

Fixed Dose Combination

DRUG

Fluticasone propionate

Fixed Dose Combination

DRUG

Salmeterol

Fixed Dose Combination

Trial Locations (10)

10787

Klinische Forschung Berlin GbR, Berlin

22927

Pneumologisches Forschungsinstitut an der LungenClinic Grosshansdorf GmbH, Großhansdorf

23552

KLB Gesundheitsforschung Lübeck GmbH, Lübeck

53105

Universitätsklinikum Bonn AöR, Bonn

55131

Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz

60389

Praxis Dr. med. Claus Keller, Frankfurt

60596

IKF Pneumologie GmbH & Co. KG, Frankfurt

69126

Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg, Heidelberg

83022

RoMed Kliniken, Rosenheim

96049

CIMS Studienzentrum Bamberg GmbH, Bamberg

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY